If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

14 Jun 2007 07:01

Fabian Romania Property Fund Ltd14 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or the "Fund") Fabian Romania announces the acquisition of an €8.0 million office developmentscheme in Bucharest Fabian Romania has signed a turn-key agreement with Hil Construct to purchaseits sixth office project in central Bucharest for a prospective purchase yieldof 8.9 per cent.. Completion is conditional on the attainment of the finalbuilding permit which is currently expected at the end of August 2007. The Romana office building will be built for the Fund on a centrally locatedsite on Dacia Boulevard. The building will be built to Class A specificationswith a gross area of approximately 3,000 square metres ("sqm"). The projectmanagement will be undertaken by Globus, an experienced local developer inRomania. Construction is due to commence in the fourth quarter 2007 withcompletion anticipated in the third quarter of 2009. Total construction costsare estimated to be in the order of €8.0 million. Upon completion, the building will provide a net lettable office area of around2,480 sqm over 7 floors, together with 40 car parking spaces. The building is ina prominent position with views over Plaza Romana and is likely to attractinternational tenants seeking Class A office space. Vacancy rates for Class Aoffice space in in Bucharest are less than 3 per cent.. The Fund, advised by itsinvestment manager Fabian Capital Limited ("Fabian Capital"), will assume theletting responsibility for the building. The estimated rental value of thebuilding upon completion is €715,000 per annum giving a prospective purchaseyield of 8.9 per cent.. Upon completion the Fund will pay the purchase price of €7.6 million to Hil in 3instalments; a first instalment of €2.0 million will be made for the company toacquire ownership of the land; a second instalment for construction costs ofapproximately €3.0 million; and a final payment upon practical completion of€2.6 million in the form of a bank guarantee. Including non developer relatedcosts, the total purchase price is forecast to be €8.0 million. The Fund'sequity requirement is expected to be €2 million with debt finance to fund thebalance. Dacia Boulevard is in the heart of Bucharest running between Calle Victoria andRomana Square. It is some 5 minutes by car from the Intercontinental Hotel. Thisarea is a popular office location. A number of international companies havetheir headquarters nearby. Commenting on the transaction, Mark Owen, Property Director of Fabian Capital,said: "We are pleased the Fund has signed another high quality office purchase shortlyafter the announcement of its intention to purchase the Evocenter. This newdevelopment is located in one of the most central positions you could hope toachieve in Bucharest and we are confident the Fund will achieve pre lets priorto completion. The building is flexible to provide sub 1,000 sqm floor plates ofwhich there is an under supply in the market whilst still otherwise providingClass A technical specifications. This investment will make it the third in thecentral core area of Bucharest for the Funds' expanding Portfolio." The lead advisers on the transaction were DTZ (property agent), WSP (technicaladvisers) and Tuca (legal adviser). For Comments:Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd May 20247:00 amRNSInvestor presentation
30th Apr 20247:00 amRNSYear-end trading statement
16th Apr 20247:00 amRNSChange of auditor
15th Apr 20247:00 amRNSContract to develop a bespoke OptiPhage library
2nd Apr 20242:34 pmRNSBlock admission six monthly return
28th Mar 20245:00 pmRNSTotal Voting Rights
11th Mar 20243:04 pmRNSHolding(s) in Company
11th Mar 20249:10 amRNSHolding(s) in Company
8th Mar 20243:09 pmRNSHolding(s) in Company
5th Mar 202410:40 amRNSResult of General Meeting and Total Voting Rights
29th Feb 20245:00 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSFirst purchase order under MSA
14th Feb 20247:15 amRNSGrant of options and issue of shares to directors
14th Feb 20247:00 amRNSPlacing to raise £1,375,000
6th Feb 20247:00 amRNSFollow-on project award and R&D update
1st Feb 20247:00 amRNSHMRC R&D tax credit
4th Dec 202312:26 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSHalf-year Report
28th Nov 20237:00 amRNSOptiMAL collaboration agreement
9th Nov 20237:00 amRNSHalf year trading update
27th Oct 202311:57 amRNSResult of AGM
4th Oct 20232:45 pmRNSBlock admission six monthly return
29th Sep 20237:00 amRNSFinal Results
29th Aug 20237:00 amRNSUpdate on AI/ML-Ab service offering
24th Aug 20237:00 amRNSAppointment of interim CFO
21st Aug 20237:00 amRNSUpdate on AI/ML-Ab™ antibody discovery service
14th Aug 20237:00 amRNSUpdate on restructure and cost savings
30th Jun 20235:00 pmRNSTotal Voting Rights
16th Jun 202310:09 amRNSHolding(s) in Company
15th Jun 20239:45 amRNSHolding(s) in Company
13th Jun 20232:44 pmRNSHolding(s) in Company
12th Jun 20233:34 pmRNSHolding(s) in Company
12th Jun 202311:02 amRNSDirector/PDMR Shareholding
8th Jun 202310:39 amRNSResult of GM and total voting rights
31st May 20235:00 pmRNSTotal Voting Rights
26th May 20234:57 pmRNSHolding(s) in Company
26th May 20231:33 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResult of Retail Offer and Notice of GM
19th May 202310:01 amRNSREX Retail Offer
19th May 202310:00 amRNSPlacing, Subscription and Retail Offer
3rd Apr 20237:00 amRNSBlock listing Interim Review
31st Mar 20237:00 amRNSChange of Registered Office
21st Mar 20237:00 amRNSPatent application
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 20237:00 amRNSTrading Statement
9th Feb 20237:00 amRNSR&D update: Mammalian Display service
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.